The melatonin receptor subtype MT2 is present in the human cardiovascular system.
about
Exogenous melatonin administration modifies cutaneous vasoconstrictor response to whole body skin cooling in humans.Myocardial ischemia-reperfusion injury: Possible role of melatoninMT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteriesGenetic aspects of melatonin biology.Melatonin inhibits nitric oxide signaling by increasing PDE5 phosphorylation in coronary arteries.Melatonin as a potential antihypertensive treatment.Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists.Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities?Dipper and non-dipper blood pressure 24-hour patterns: circadian rhythm-dependent physiologic and pathophysiologic mechanisms.Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.Expression and putative functions of melatonin receptors in malignant cells and tissues.Sleep Medications Containing Melatonin can Potentially Induce Ventricular Arrhythmias in Structurally Normal Hearts: A 2-Patient ReportThe P2Y1 receptor-mediated leukocyte adhesion to endothelial cells is inhibited by melatonin.Melatonin and Human Cardiovascular Disease.Maternal melatonin administration mitigates coronary stiffness and endothelial dysfunction, and improves heart resilience to insult in growth restricted lambs.Reduced hippocampal MT2 melatonin receptor expression in Alzheimer's disease.Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats.Microcirculatory effects of melatonin in rat skeletal muscle after prolonged ischemia.Sustained anti-beta-adrenergic effect of melatonin in guinea pig heart papillary muscle.The effect of myocardial infarction on the synthesis, concentration and receptor expression of endogenous melatonin.Intracoronary melatonin increases coronary blood flow and cardiac function through β-adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs.Melatonin attenuated brain death tissue extract-induced cardiac damage by suppressing DAMP signaling.Melatonin counteracts the loss of agonist-evoked contraction of aortic rings induced by incubation.The presence and localization of melatonin receptors in the rat aorta.A case-control study of melatonin receptor type 1A polymorphism and acute myocardial infarction in a Spanish population.
P2860
Q33320692-E8CE6F55-B806-4563-B55F-F7F0C84C9A4AQ34390698-19E6DDB9-FDE5-492F-8E6F-A48FC210723AQ34458636-CEA4233F-C073-457A-AA00-3F0C8DAD22C0Q35882505-73900072-349D-401E-8A2F-0CDDD01EF6F6Q36494644-2282E3ED-403E-4616-95AD-814B3A8EFEA8Q36793940-2309B22B-87BE-4067-B4B3-432C7ABA041AQ37404821-56106004-BBDF-4A1C-BB69-70F13BBDABD4Q37763715-4592E345-A915-4BB5-90FB-C6A0DBE3C982Q37973897-FE1FD7DA-46AF-4404-9535-B7E4F951D262Q38045905-C3A99AAD-4C73-4974-891F-B4E94C1F4079Q38053166-F74E4F54-FAB6-44EB-B0E1-2A5BB5BCE345Q38229317-BAC43F13-EC48-46B0-9C91-AF822F2283E2Q38678951-CF2B3ED2-5106-43E7-AAB8-4ACA2F27C8C8Q38757896-2C9DF36B-23A9-4960-9AD9-9D075C2FF20EQ38906296-48E033D6-605C-4DE1-BAAA-7EA79A64231CQ39263899-A0FEBC33-294F-4D39-B69F-AEDCFE4CAA8DQ40477472-4EDC55FD-2F68-4F30-97A2-94FDB642C652Q46099814-578B17E1-0BA2-4BAA-858F-93A9A669C9B8Q46566162-E6D4CC4C-7537-409F-BFA0-A9A37141D251Q46624978-39813177-D914-4F9B-BE35-F688D54625EAQ48248895-8C397F09-08BF-4770-86CB-262DDC135E53Q48266159-8AE24EA5-4D6D-4DF8-8800-3E0E06F9D946Q50043120-228760A8-7926-43CF-BF32-DD99692BF419Q50996967-86AB13EB-F78F-4EC6-A13F-A4D6EE3D3217Q54363570-D31058F4-3D9E-4181-8EEF-84E0E5908F53Q54367778-A04E42F7-D3D1-43F7-A4C3-2F68F427B0BE
P2860
The melatonin receptor subtype MT2 is present in the human cardiovascular system.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
The melatonin receptor subtype MT2 is present in the human cardiovascular system.
@en
The melatonin receptor subtype MT2 is present in the human cardiovascular system.
@nl
type
label
The melatonin receptor subtype MT2 is present in the human cardiovascular system.
@en
The melatonin receptor subtype MT2 is present in the human cardiovascular system.
@nl
prefLabel
The melatonin receptor subtype MT2 is present in the human cardiovascular system.
@en
The melatonin receptor subtype MT2 is present in the human cardiovascular system.
@nl
P2093
P2860
P1476
The melatonin receptor subtype MT2 is present in the human cardiovascular system.
@en
P2093
Cem Ekmekcioglu
Gerhard Strauss-Blasche
Helmut D Glogar
Mohammad R Mehrabi
Ognjen Markovic
Susanne Humpeler
Theresia Thalhammer
Thomas Hölzenbein
Valentin J Leibetseder
Wolfgang Marktl
P2860
P356
10.1034/J.1600-079X.2003.00051.X
P577
2003-08-01T00:00:00Z